Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

AADI BIOSCIENCE, INC.

(AADI)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Health Care Stocks Partially Recover From Morning Slide

11/23/2021 | 01:52pm EST


ę MT Newswires 2021
All news about AADI BIOSCIENCE, INC.
01/20AADI BIOSCIENCE : Material Definitive Agreement - Form 8-K
PU
01/20Aadi Bioscience, Inc. Enters into Certain Negotiated Purchase Order Terms and Condition..
CI
01/20AADI BIOSCIENCE, INC. : Entry into a Material Definitive Agreement (form 8-K)
AQ
01/20Canadian Biotech Disruptor Lexston Life Sciences is unlocking the God Molecule (LEXTF, ..
AQ
01/11Jefferies Starts Aadi Bioscience at Buy With $45 Price Target
MT
01/04Aadi Bioscience to Present at 2022 H.C. Wainwright BioConnect Virtual Conference
GL
2021AADI BIOSCIENCE, INC.(NASDAQCM : AADI) added to S&P Biotechnology Select Industry Index
CI
2021AADI BIOSCIENCE : Corporate Overview
PU
2021HC Wainwright Adjusts Aadi Bioscience's Price Target to $49 From $47, Keeps Buy Rating
MT
2021Health Care Stocks Nudging Back Onto Positive Ground
MT
More news
Analyst Recommendations on AADI BIOSCIENCE, INC.
More recommendations
Financials (USD)
Sales 2021 0,06 M - -
Net income 2021 -111 M - -
Net Debt 2021 - - -
P/E ratio 2021 -2,98x
Yield 2021 -
Capitalization 388 M 388 M -
Capi. / Sales 2021 6 463x
Capi. / Sales 2022 127x
Nbr of Employees 21
Free-Float -
Chart AADI BIOSCIENCE, INC.
Duration : Period :
Aadi Bioscience, Inc. Technical Analysis Chart | AADI | US00032Q1040 | MarketScreener
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 5
Last Close Price 18,56 $
Average target price 48,75 $
Spread / Average Target 163%
EPS Revisions
Managers and Directors
Neil P. Desai President, CEO, Secretary & Director
Scott M. Giacobello Treasurer, Chief Financial & Accounting Officer
Caley M. Castelein Chairman
Loretta M. Itri Chief Medical Officer
Brendan Delaney Chief Operating Officer
Sector and Competitors
1st jan.Capi. (M$)
AADI BIOSCIENCE, INC.-23.15%388
GILEAD SCIENCES, INC.-7.35%84 382
REGENERON PHARMACEUTICALS-4.16%63 645
VERTEX PHARMACEUTICALS3.93%58 082
WUXI APPTEC CO., LTD.-12.95%47 040
BIONTECH SE-40.05%37 325